Výsledky vyhledávání - "Neil Lamarre"

Akademický článek

Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA

Autor: Sikander Ailawadhi, Arliene Ravelo, Carmen D Ng, Bonny Shah, Neil Lamarre, Rongrong Wang, Katherine Eakle, Juliana ML Biondo

Publikováno v: Journal of Comparative Effectiveness Research, Vol 13, Iss 2 (2024)

Aim: Improved management of chronic lymphocytic leukemia (CLL) has resulted in a growing population of CLL survivors; these patients have a higher risk of developing second primary malignancies (SPMs) versus the general population. This retrospecti

Externí odkaz: https://doaj.org/article/faadf5cffea44b4aa41ecc512af99f90

Zobrazit plný text záznamu

Akademický článek

Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study

Autor: Thibaut Sanglier, Jinjoo Shim, Neil Lamarre, Claudia Peña-Murillo, Vincent Antao, Filippo Montemurro

Publikováno v: Breast, Vol 69, Iss , Pp 441-450 (2023)

Background: Trastuzumab emtansine (T-DM1) has demonstrated improvements in survival and neurological symptoms in patients with breast cancer with brain metastases (BCBM). This real-world study investigated the effectiveness of T-DM1 versus lapatinib

Externí odkaz: https://doaj.org/article/dc6441ba5eec4f8093e6c924597ba37f

Zobrazit plný text záznamu

Akademický článek

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma

Autor: Kenneth H. Yu, Paul Cockrum, Andy Surinach, Neil Lamarre, Shu Wang, Eileen M. O'Reilly

Publikováno v: Cancer Medicine, Vol 12, Iss 8, Pp 9496-9505 (2023)

Abstract Background Subgroup analyses of the NAPOLI‐1 study identified that among patients who were irinotecan naïve prior to entering the clinical trial, a survival benefit was observed between the study arm and control arm. This treatment benefi

Externí odkaz: https://doaj.org/article/0f119c35950048d1824f7cadc9131a94

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Autor: Ben George, Matthew Kent, Andy Surinach, Neil Lamarre, Paul Cockrum

Publikováno v: Frontiers in Oncology, Vol 11 (2021)

BackgroundPancreatic cancer is expected to be the third deadliest cancer in the US in 2021. Evaluation of treatment response in patients with mPDAC necessitates scheduled clinical and radiographic assessments along with monitoring serum CA 19-9 level

Externí odkaz: https://doaj.org/article/59e9cca4c10a47629833b538ba0a0db0

Zobrazit plný text záznamu

The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Autor: Neil Lamarre, Paul Cockrum, Andy Surinach, Ben George, Matthew Kent

Publikováno v: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90081579dc0a8a481aca0f0f299c7272
https://pubmed.ncbi.nlm.nih.gov/34671563

Zobrazit plný text záznamu

Real-world clinical outcomes of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan-based regimens: Impact of prior irinotecan (IRI) exposure

Autor: Kenneth H. Yu, Paul Cockrum, Andy Surinach, Neil Lamarre, Shu Wang, Eileen Mary O'Reilly

Publikováno v: Journal of Clinical Oncology. 40:580-580

580 Background: Subgroup analyses of the NAPOLI-1 study identified that among patients who were IRI naïve prior to entering the clinical trial, a survival benefit was observed between the study arm and control arm (overall survival (OS): 6.7 months

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2aa062d61d4e70ae2d72578e2ac54d8
https://doi.org/10.1200/jco.2022.40.4_suppl.580

Zobrazit plný text záznamu

Abstract 765: Real-world serum CA19-9 level monitoring patterns and its association with clinical outcomes among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)

Autor: Ben George, Aleksander Chudnovsky, Paul Cockrum, Andy Surinach, Matthew Kent, Neil Lamarre

Publikováno v: Cancer Research. 81:765-765

Background: Pancreatic cancer is expected to be the third deadliest cancer in the US in 2020. Evaluation of treatment response in patients (pts) with mPDAC necessitates scheduled clinical and radiographic assessments along with monitoring serum CA 19

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f8efe2a5506237e0e01900255e36ded
https://doi.org/10.1158/1538-7445.am2021-765

Zobrazit plný text záznamu

The association between real-world CA19-9 level monitoring patterns and with clinical outcomes among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the second- and third-line of therapy

Autor: Ben George, Andy Surinach, Neil Lamarre, Matthew Kent, Aleksander Chudnovsky, Paul Cockrum

Publikováno v: Journal of Clinical Oncology. 39:e16251-e16251

e16251 Background: Pancreatic cancer has an aggressive disease course, mandating close clinical monitoring while on treatment. Evaluation of treatment response in patients with mPDAC necessitates scheduled clinical and radiographic assessments along

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::502dd7c157a096f4f275a60e5e5683ba
https://doi.org/10.1200/jco.2021.39.15_suppl.e16251

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání